Patents by Inventor Anne Girod

Anne Girod has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Structural protein of adeno-associated virus with modified antigenicity, its production and its use
    Patent number: 7968340
    Abstract: The present invention relates to a structural protein of adeno-associated virus (AAV) which comprises at least one modification which brings about a reduction in the antigenicity, its production and use.
    Type: Grant
    Filed: June 15, 2009
    Date of Patent: June 28, 2011
    Assignee: MediGene AG
    Inventors: Michael Hallek, Anne Girod, Martin Ried
  • AAV SCLEROPROTEIN, PRODUCTION AND USE THEREOF
    Publication number: 20110052617
    Abstract: The invention relates to a structural protein of adeno-associated virus (AAV) which comprises at least one mutation which brings about an increase in the infectivity of the virus.
    Type: Application
    Filed: December 1, 2009
    Publication date: March 3, 2011
    Applicant: MEDIGENE AKTIENGESELLSCHAFT
    Inventors: Michael Hallek, Martin Ried, Gilbert Deleage, Anne Girod
  • SCLEROPROTEIN OF AN ADENO-ASSOCIATED VIRUS WITH MODIFIED CHROMATOGRAPHIC PROPERTIES, THE PRODUCTION THEREOF AND USE OF THE SAME
    Publication number: 20100105123
    Abstract: The invention relates to a scleroprotein of an adeno-associated virus which contains at least one mutation. Said mutation causes the chromatographic properties to be modified. The invention also relates to the production of said scleroprotein and the use thereof.
    Type: Application
    Filed: September 24, 2007
    Publication date: April 29, 2010
    Applicant: MEDIGENE AKTIENGESELLSCHAFT
    Inventors: Michael Hallek, Anne Girod, Martin Ried, Christof Stolla, Ulrich Moebius
  • STRUCTURAL PROTEIN OF ADENO-ASSOCIATED VIRUS WITH MODIFIED ANTIGENICITY, ITS PRODUCTION AND ITS USE
    Publication number: 20090253897
    Abstract: The present invention relates to a structural protein of adeno-associated virus (AAV) which comprises at least one modification which brings about a reduction in the antigenicity, its production and use.
    Type: Application
    Filed: June 15, 2009
    Publication date: October 8, 2009
    Applicant: MediGene AG
    Inventors: Michael Hallek, Anne Girod, Martin Ried
  • SCLEROPROTEIN OF AN ADENO-ASSOCIATED VIRUS WITH MODIFIED CHROMATOGRAPHIC PROPERTIES, THE PRODUCTION THEREOF AND USE OF THE SAME
    Publication number: 20090246854
    Abstract: The invention relates to a scleroprotein of an adeno-associated virus which contains at least one mutation. Said mutation causes the chromatographic properties to be modified. The invention also relates to the production of said scleroprotein and the use thereof.
    Type: Application
    Filed: September 24, 2007
    Publication date: October 1, 2009
    Applicant: MEDIGENE AKTIENGESELLSCHAFT
    Inventors: Michael Hallek, Anne Girod, Martin Ried, Christof Stolla, Ulrich Moebius
  • Structural protein of adeno-associated virus with modified antigenicity, its production and its use
    Patent number: 7556965
    Abstract: The present invention relates to a structural protein of adeno-associated virus (AAV) which comprises at least one modification which brings about a reduction in the antigenicity, its production and use.
    Type: Grant
    Filed: July 23, 2007
    Date of Patent: July 7, 2009
    Assignee: MediGene AG
    Inventors: Michael Hallek, Anne Girod, Martin Reid
  • SCLEROPROTEIN OF AN ADENO ASSOCIATED VIRUS WITH MODIFIED CHROMATOGRAPHIC PROPERTIES, THE PRODUCTION THEREOF AND USE OF THE SAME
    Publication number: 20090098634
    Abstract: The invention relates to a scleroprotein of an adeno-associated virus which contains at least one mutation. Said mutation causes the chromatographic properties to be modified. The invention also relates to the production of said scleroprotein and the use thereof.
    Type: Application
    Filed: September 24, 2007
    Publication date: April 16, 2009
    Applicant: MEDIGENE AKTIENGESELLSCHAFT
    Inventors: Michael HALLEK, Anne GIROD, Martin RIED, Christof STOLLA, Ulrich MOEBIUS
  • Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same
    Publication number: 20080241906
    Abstract: The invention relates to a scleroprotein of an adeno-associated virus which contains at least one mutation. Said mutation causes the chromatographic properties to be modified. The invention also relates to the production of said scleroprotein and the use thereof.
    Type: Application
    Filed: September 24, 2007
    Publication date: October 2, 2008
    Inventors: Michael Hallek, Anne Girod, Martin Ried, Christof Korner, Ulrich Moebius
  • Structural protein of adeno-associated virus with modified antigenicity, its production and its use
    Publication number: 20080064081
    Abstract: The present invention relates to a structural protein of adeno-associated virus (AAV) which comprises at least one modification which brings about a reduction in the antigenicity, its production and use.
    Type: Application
    Filed: July 23, 2007
    Publication date: March 13, 2008
    Inventors: Michael Hallek, Anne Girod, Martin Ried
  • AAv scleroprotein, production and use thereof
    Patent number: 7314912
    Abstract: The invention relates to a structural protein of adeno-associated virus (AAV) which comprises at least one mutation which brings about an increase in the infectivity of the virus.
    Type: Grant
    Filed: June 21, 1999
    Date of Patent: January 1, 2008
    Assignee: Medigene Aktiengesellschaft
    Inventors: Michael Hallek, Martin Ried, Gilbert Deleage, Anne Girod
  • Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same
    Patent number: 7285381
    Abstract: The invention relates to a scleroprotein of an adeno-associated virus which contains at least one mutation. Said mutation causes the chromatographic properties to be modified. The invention also relates to the production of said scleroprotein and the use thereof.
    Type: Grant
    Filed: July 18, 2000
    Date of Patent: October 23, 2007
    Assignee: MediGene Aktiengesellschaft
    Inventors: Michael Hallek, Anne Girod, Martin Ried, Christof Körner, Ulrich Moebius
  • AAV scleroprotein, production and use thereof
    Publication number: 20070238684
    Abstract: The invention relates to a structural protein of adeno-associated virus (AAV) which comprises at least one mutation which brings about an increase in the infectivity of the virus.
    Type: Application
    Filed: December 28, 2006
    Publication date: October 11, 2007
    Applicant: MEDIGENE AKTIENGESELLSCHAFT
    Inventors: Michael Hallek, Martin Ried, Gilbert Deleage, Anne Girod
  • Structural protein of adeno-associated virus with modified antigenicity, its production and its use
    Patent number: 7252997
    Abstract: The invention relates to a structural protein of adeno-associated virus (AAV) that contains at least one modification that reduces the antigenicity of the virus. The invention further relates to the production of the structural protein and to its use.
    Type: Grant
    Filed: July 13, 2000
    Date of Patent: August 7, 2007
    Assignee: MediGene AG
    Inventors: Michael Hallek, Anne Girod, Martin Ried